Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366417 · ClinicalTrials.gov registry record · Phase 4
Topical Antimicrobial Effectiveness Testing
A Phase 4 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT01366417 is a Phase 4 study that has completed, run by C. R. Bard. The registered enrollment target is 25 participants.
The verdict
NCT01366417, a Phase 4 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep One-Step Frepp Applicator.
Interventions
- DRUG ChloraPrep One-Step
- DRUG 70% isopropyl alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366417
The ClinicalTrials.gov registry entry for NCT01366417 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ChloraPrep One-Step is the first listed.
NCT01366417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366417 about?
NCT01366417 is a clinical study titled "Topical Antimicrobial Effectiveness Testing". The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep One-Step Frepp Applicator.
What is the current status of trial NCT01366417?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2011-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01366417?
The interventions under investigation include: ChloraPrep One-Step (DRUG), 70% isopropyl alcohol (DRUG).
Who is sponsoring clinical trial NCT01366417?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.